Wave Life Sciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-102.0M | $-55.7M | $-19.2M | $-5.2M | $-3.3M |
| Depreciation & Amortization | $2.2M | $784.0K | $594.0K | $281.0K | $276.0K |
| Depreciation | $2.2M | $784.0K | — | — | — |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | — | — | $4.0M | — | — |
| Net Cash from Operating Activities | $-83.7M | $-31.9M | $-12.5M | $-4.4M | $-3.6M |
| Investing Activities | |||||
| Capital Expenditures | $18.9M | $5.6M | $1.9M | $590.0K | $47.0K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-18.9M | $-5.6M | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $94.4M | $29.1M | — | — | — |
| Net Change in Cash | $-7.8M | $-10.9M | $160.2M | $609.0K | $60.0K |
| Free Cash Flow | $-102.6M | $-37.5M | $-14.4M | $-5.0M | $-3.6M |